Frankfurt - Delayed Quote EUR
Merus N.V. (2GH.F)
32.60
-3.80
(-10.44%)
At close: 3:29:01 PM GMT+2
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.41M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
LUNDBERG SVEN ANTE Chief Executive Officer | Conversion of Exercise of derivative security at price 12.54 - 13.52 per share. | Direct | 405,894 | Apr 17, 2025 |
SHUMAN HARRY Officer | -- | Direct | -- | Mar 21, 2025 |
SHUMAN HARRY Officer | Sale at price 48.48 - 48.55 per share. | Direct | 193,990 | Mar 21, 2025 |
LUNDBERG SVEN ANTE Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 19, 2025 |
LUNDBERG SVEN ANTE Chief Executive Officer | Conversion of Exercise of derivative security at price 24.43 per share. | Direct | 399,968 | Feb 13, 2025 |
SHUMAN HARRY Officer | -- | Direct | -- | Dec 31, 2024 |
SHUMAN HARRY Officer | -- | Direct | -- | Aug 21, 2024 |
SHUMAN HARRY Officer | Sale at price 54.00 per share. | Direct | 270,000 | Aug 21, 2024 |
SILVERMAN PETER B. Chief Operating Officer | Conversion of Exercise of derivative security at price 17.94 per share. | Direct | 179,400 | Jun 27, 2024 |
SILVERMAN PETER B. Chief Operating Officer | Sale at price 60.00 per share. | Direct | 600,000 | Jun 27, 2024 |
SILVERMAN PETER B. Chief Operating Officer | Conversion of Exercise of derivative security at price 17.94 - 25.90 per share. | Direct | 1,510,280 | Jun 17, 2024 |
SILVERMAN PETER B. Chief Operating Officer | Sale at price 56.52 per share. | Direct | 3,504,178 | Jun 17, 2024 |
SHUMAN HARRY Officer | Conversion of Exercise of derivative security at price 13.23 - 25.62 per share. | Direct | 145,226 | Jun 12, 2024 |
SHUMAN HARRY Officer | Sale at price 53.22 - 57.84 per share. | Direct | 475,456 | Jun 12, 2024 |
SHUMAN HARRY Officer | -- | Direct | -- | Jun 4, 2024 |
SHUMAN HARRY Officer | Sale at price 52.85 - 53.12 per share. | Direct | 317,354 | Jun 4, 2024 |
SHUMAN HARRY Officer | Sale at price 26.68 per share. | Direct | 3,068 | Dec 19, 2023 |
SILVERMAN PETER B. Chief Operating Officer | Conversion of Exercise of derivative security at price 11.16 - 12.37 per share. | Direct | 251,384 | Dec 15, 2023 |
SILVERMAN PETER B. Chief Operating Officer | Sale at price 25.00 per share. | Direct | 559,650 | Dec 15, 2023 |
SHUMAN HARRY Officer | Sale at price 24.44 per share. | Direct | 6,110 | Dec 8, 2023 |
SHUMAN HARRY Officer | -- | Direct | -- | Dec 1, 2023 |
SHUMAN HARRY Officer | Sale at price 24.58 per share. | Direct | 14,134 | Dec 1, 2023 |
SHUMAN HARRY Officer | -- | Direct | -- | Jun 1, 2023 |
SHUMAN HARRY Officer | Sale at price 21.48 per share. | Direct | 12,351 | Jun 1, 2023 |
Related Tickers
2BO.F Serina Therapeutics Inc. R
5.10
+10.87%
ZA71.F Larimar Therapeutics, Inc.
1.9400
-6.73%
PCJ.F Abeona Therapeutics Inc.
4.5000
-2.17%
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
NEXI NexImmune, Inc.
0.0001
0.00%
SER Serina Therapeutics, Inc.
6.09
+5.36%
CRGX CARGO Therapeutics, Inc.
4.5250
-0.55%
CTNM Contineum Therapeutics, Inc.
4.5200
-4.64%
VALN Valneva SE
6.99
+1.75%
SION Sionna Therapeutics, Inc.
12.60
-3.74%